Skip to main content
. Author manuscript; available in PMC: 2013 Mar 22.
Published in final edited form as: Transfusion. 2011 Mar 29;51(10):2078–2091. doi: 10.1111/j.1537-2995.2011.03120.x

TABLE 5.

TRALI and possible TRALI diagnoses by sex, parity, and HLA antibody of the LAPS-II donor whose component was transfused*

Study
Control
Total
Females with pregnancies
Females with pregnancies
Females with pregnancies
Diagnosis Male and never-pregnant females (n = 99) One pregnancy (n = 99) Two pregnancies (n = 328) Three or more pregnancies (n = 669) Male and never-pregnant females (n = 103) One pregnancy (n = 103) Two pregnancies (n = 349) Three or more pregnancies) (n = 678) Male and never-pregnant females (n = 202) One pregnancy (n = 202) Two pregnancies (n = 677) Three or more pregnancies (n = 1347) p value (exact test)
TRALI 0 0 1 (0.30) 6 (0.90) 0 0 0 2 (0.29) 0 0 1 (0.15) 8 (0.59) 0.13
Possible TRALI 1 (1.01) 2 (2.02) 2 (0.61) 4 (0.60) 0 0 3 (0.86) 5 (0.74) 1 (0.50) 2 (0.99) 5 (0.74) 9 (0.67) 0.97
TRALI or possible TRALI 1 (1.01) 2 (2.02) 3 (0.91) 10 (1.49) 0 0 3 (0.86) 7 (1.03) 1 (0.50) 2 (0.99) 6 (0.89) 17 (1.26) 0.71
*

Data are reported as number (%).

p value is computed only among the total columns and compares rates among the four sex/parity classifications.